Phosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70S6 kinase

被引:459
作者
Chiang, GG [1 ]
Abraham, RT [1 ]
机构
[1] Burnham Inst, Program Signal Transduct Res, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.M501707200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian target of rapamycin ( mTOR) coordinates cell growth with the growth factor and nutrient/ energy status of the cell. The phosphatidylinositol 3kinase- AKT pathway is centrally involved in the transmission of mitogenic signals to mTOR. Previous studies have shown that mTOR is a direct substrate for the AKT kinase and identified Ser- 2448 as the AKT target site in mTOR. In this study, we demonstrate that rapamycin, a specific inhibitor of mTOR function, blocks serum- stimulated Ser- 2448 phosphorylation and that this drug effect is not explained by the inhibition of AKT. Furthermore, the phosphorylation of Ser- 2448 was dependent on mTOR kinase activity, suggesting that mTOR itself or a protein kinase downstream from mTOR was responsible for the modification of Ser- 2448. Here we show that p70S6 kinase phosphorylates mTOR at Ser- 2448 in vitro and that ectopic expression of rapamycin- resistant p70S6 kinase restores Ser- 2448 phosphorylation in rapamycintreated cells. In addition, we show that cellular amino acid status, which modulates p70S6 kinase ( S6K1) activity via the TSC/ Rheb pathway, regulates Ser- 2448 phosphorylation. Finally, small interfering RNA- mediated depletion of p70S6 kinase reduces Ser- 2448 phosphorylation in cells. Taken together, these results suggest that p70S6 kinase is a major effector of mTOR phosphorylation at Ser- 2448 in response to both mitogenand nutrient- derived stimuli.
引用
收藏
页码:25485 / 25490
页数:6
相关论文
共 42 条
[41]  
WENG QP, 1995, MOL CELL BIOL, V15, P2333
[42]   Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers [J].
Zhou, XY ;
Tan, M ;
Hawthorne, VS ;
Klos, KS ;
Lan, KH ;
Yang, Y ;
Yang, WT ;
Smith, TL ;
Shi, DR ;
Yu, DH .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6779-6788